Yu, Y., Zou, Y., Hong, R., Chen, W., Chen, L., Chen, W., . . . Yu, Y. (2022). Long non‐coding RNA SNHG16 decreased SMAD4 to induce gemcitabine resistance in pancreatic cancer via EZH2‐mediated epigenetic modification. Wiley.
Chicago Style (17th ed.) CitationYu, Yi, Yu‐Feng Zou, Run‐Qi Hong, Wen‐Jie Chen, Liang Chen, Wen‐Qi Chen, Hui‐Peng Wang, and Yuan Yu. Long Non‐coding RNA SNHG16 Decreased SMAD4 to Induce Gemcitabine Resistance in Pancreatic Cancer via EZH2‐mediated Epigenetic Modification. Wiley, 2022.
MLA (9th ed.) CitationYu, Yi, et al. Long Non‐coding RNA SNHG16 Decreased SMAD4 to Induce Gemcitabine Resistance in Pancreatic Cancer via EZH2‐mediated Epigenetic Modification. Wiley, 2022.
Warning: These citations may not always be 100% accurate.